Page last updated: 2024-08-23

raloxifene hydrochloride and Hypercalcemia

raloxifene hydrochloride has been researched along with Hypercalcemia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Alfadhli, EM	1
Sugimoto, T	1
Gowda, S; Mahaseth, HC; Prabhu, H; Shah, BK; Vieira, J	1
Nakamura, T	1
Cosman, F; Glass, EV; Krege, JH; Recknor, CP; Wermers, RA; Xie, L	1

Reviews

3 review(s) available for raloxifene hydrochloride and Hypercalcemia

Article	Year
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic. Clinical therapeutics, 2021, Volume: 43, Issue:4 Topics: Bone Density; Calcium; Cinacalcet; COVID-19; Diphosphonates; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Middle Aged; Parathyroidectomy; Raloxifene Hydrochloride; Vitamin D	2021
[Progress in diagnosis and therapy: Hypercalcemia due to primary hyperparathyroidism]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Apr-10, Volume: 96, Issue:4 Topics: Alendronate; Biomarkers; Bone Density Conservation Agents; Calcium; Diagnosis, Differential; Diagnostic Imaging; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Parathyroid Hormone; Parathyroidectomy; Polymorphism, Genetic; Raloxifene Hydrochloride; Receptors, Calcium-Sensing; Selective Estrogen Receptor Modulators; Vitamin D	2007
[Adverse events of drugs for the treatment of osteoporosis]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8 Topics: Bone Density Conservation Agents; Cardiovascular Diseases; Cholecalciferol; Diphosphonates; Gastrointestinal Diseases; Hot Flashes; Humans; Hypercalcemia; Jaw Diseases; Macular Edema; Necrosis; Osteoporosis; Raloxifene Hydrochloride; Venous Thrombosis	2007

Trials

1 trial(s) available for raloxifene hydrochloride and Hypercalcemia

Article	Year
Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:7 Topics: Aged; Alendronate; Bone Density Conservation Agents; Calcium; Drug Combinations; Female; Humans; Hypercalcemia; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Teriparatide	2008

Article

Year

Effects of teriparatide on serum calcium in postmenopausal women with osteoporosis previously treated with raloxifene or alendronate.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:7

Topics: Aged; Alendronate; Bone Density Conservation Agents; Calcium; Drug Combinations; Female; Humans; Hypercalcemia; Osteoporosis, Postmenopausal; Prospective Studies; Raloxifene Hydrochloride; Teriparatide

2008

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Hypercalcemia

Article	Year
Modern milk alkali syndrome--a preventable serious condition. The New Zealand medical journal, 2007, Sep-21, Volume: 120, Issue:1262 Topics: Alendronate; Bone Density Conservation Agents; Calcium; Diuretics; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Middle Aged; Raloxifene Hydrochloride; Treatment Outcome	2007